Format

Send to

Choose Destination
Lancet. 1992 Aug 15;340(8816):397-8.

Effect of indomethacin plus ranitidine in advanced melanoma patients on high-dose interleukin-2.

Author information

1
Department of Medical Oncology, London Regional Cancer Centre, Canada.

Abstract

Preclinical models of advanced melanoma have shown that chronic indomethacin therapy combined with interleukin 2 (IL-2) can eradicate experimental metastases. A phase II trial was done in patients with advanced melanoma. Indomethacin and ranitidine were begun at least one week before IL-2. Of the objective responses in 3 patients, 2 were achieved on ranitidine and indomethacin alone, before start of IL-2. Indomethacin and ranitidine may be responsible for some responses in melanoma patients previously attributed to IL-2.

PMID:
1353559
DOI:
10.1016/0140-6736(92)91474-m
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science Icon for MLibrary (Deep Blue)
Loading ...
Support Center